Hiv Clinical Trial
Official title:
Action for Positive Brain Health Now: Ready, Set, Go
HIV (human immunodeficiency virus) can have subtle but important effects on the brain, leading to difficulties in memory, concentration, or problem solving. Goal-setting interventions have been shown to help individuals maintain their physical activity in order to improve brain health. The study objective is to estimate the extent to which goal management training before a personalized healthy lifestyle program is associated with greater adherence to health recommendations, achievement of health-related goals, and better brain health and general health outcomes compared to the healthy lifestyle program alone. Participants will be randomized to either Goal Management Training (GMT) and a Healthy Lifestyle Program (HLP) or the control group (HLP alone).
Based on healthy aging research in HIV- populations, it is already known that many older
people living with HIV could protect or improve their brain health through lifestyle change .
However, no intervention is effective if it is not done. Sustained lifestyle change is hard
for everyone, but expected to be harder still for those with a chronic condition that affects
cognitive ability, eroding the very executive functions needed for effective goal-directed
behavior. Thus, the key question is not whether interventions will help brain health in HIV
but rather how we can improve adherence to the most promising interventions in people
experiencing brain health challenges.
This study will test an innovative approach to enhance adherence to lifestyle interventions,
building on feasibility evidence from pilot trials in the Brain Health Now (BHN) study. Goal
Management Training (GMT) is a fully manualized cognitive rehabilitation program delivered
over 9 weeks in small groups. It targets executive dysfunction, teaching self-management and
mindfulness. GMT also trains participants to use explicit strategies to reduce cognitive load
in everyday tasks, and methods to cue attention to maintain focus on specific tasks, through
weekly 2-h sessions and practice at home. We hypothesize that GMT priming before a
personalized Healthy Lifestyle Program (HLP) will improve adherence to that program and
subsequently improve health outcomes, compared to the HLP without GMT priming, in cognitively
frail men and women living with HIV.
Study objectives
The overall objective of Action for Brain Health Now is to understand, empower and act to
protect and improve brain health in HIV, in order to empower patients to take charge of their
brain health. This sub-study is directed to the third aim, act. This proposed study addresses
the real-world challenge of implementing tailored recommendations, recognizing that the
cognitively frail individuals who would benefit the most from lifestyle changes are least
equipped to successfully adopt and sustain healthy behaviours. We will trial a novel
cognitive rehabilitation approach using goal-management training to boost adherence to a
tailored active living intervention.
Specific objective
Estimate the extent to which cognitive rehabilitation before a personalized healthy lifestyle
program (HLP) is associated with greater uptake of health recommendations, achievement of
health-related goals, and better brain health and general health outcomes compared to the HLP
alone.
Methods
Design
A blinded, randomized control trial will be conducted in 100 participants at two sites
(Montreal and Vancouver) in order to assess the impact of cognitive rehabilitation on the
uptake of a healthy lifestyle program. More specifically, 50 participants will be recruited
in Montreal and 50% (i.e. 25 participants) will be assigned to the intervention group and the
other 50% (i.e. 25 participants) will be assigned to the control group. The same is true for
the site in Vancouver.
Recruitment
The eligibility criteria will be given to the data team who will do a search among the
participants and send the investigators a list of ID of potential participants. If these
potential participants have agreed, in the main study consent form, to be contacted for
sub-studies, they will get a phone call, email or will be contacted directly during a clinic
visit by the research coordinator involved in the main study (ABHN). Ethics approval for the
Glen site including Royal Victoria Hospital & Center for Innovative Medicine (CIM) /
Montreal, the Clinique Médicale l'Actuel / Montreal and Clinique Médicale Urbaine Quartier
Latin / Montreal will be obtained through the MUHC REB. A separate application for the
university-based clinic at St-Paul's Hospital / Vancouver will be sent to their own REB for
approval.
Intervention
The sample will be drawn from cohort participants. The ABHN full cohort will receive a
personalized My Personal Brain Health Dashboard populated directly from their study data
accompanied by a document with 7 Simple Tips for Better Brain Health. In addition, the
participants of this trial will receive a short list of relevant local resources (e.g.
low-cost gyms, community social groups, smoking cessation programs). To test whether a
cognitive rehabilitation program will increase healthy lifestyle adherence, people meeting
eligibility criteria will be identified and, if in Vancouver or Montreal, offered entry into
a randomized trial asking whether priming with GMT will increase adherence to a HLP focused
on physical and social activity. All of the participants who agree to enter the trial will be
invited to attend the Ready, Set Workshop which will occur before randomization at each site
(50 participants per site) and will last approximately four hours long.
Ready: All of the participants will be shown how to best interpret the My Personal Brain
Health Dashboard. All of the participants will also be provided with the Garmin vívofit 4
Activity Tracker (worn on the wrist); they will also be trained how to use the Garmin vívofit
4 Activity tracker as well as the mobile app that accompanies it, the SmartAge digital
platform for activity tracking and feedback (collaborator Guaraldi). Participants who do not
have an app compatible device will be provided with one for the duration of the study.
Set: During the Workshop there will be instruction on SMART goals and demonstration of the My
Goals app to use for recording and monitoring goals.
Go: Following the workshop, the participants will be randomized to priming with GMT as they
enter the HLP, or to entering the HLP directly. The study period will last 52 weeks for both
groups. The intervention group will participate in GMT, a standardized cognitive
rehabilitation program which will be given as per the manual, which consists of 9 sessions
each 2-hours in duration. The control group enters directly into the HLP without any other
study visits.
For all the participants, the HLP includes, physical activity monitoring (step count,
calories burned and sleep) with the Garmin vívofit 4 Activity Tracker, and recording and
monitoring of goals with the My Goals app. Moreover, participants will be offered an exercise
program with weaning to community-based resources and home exercise recommendations for
longer-term sustainability.
In addition, all participants will be assigned a HLP coach to facilitate the transition into
using community resources to meet their goals. The HLP coach will provide feedback,
encouragement, and suggestions for increasing activity via weekly phone or text interactions
throughout the HLP via the SmartAge Digital Platform. The physical activity target will be
current Canadian guidelines for older people (150 minutes per week of moderate to vigorous
exercise, accumulated in bouts of at least 10 minutes), while the social activity target will
be one social event per week. All the strategies in the HLP have evidence for effectiveness.
The participants will also be asked to track the progress of their goals on the MyGoals app
and report their participation in any activities they do by taking a picture of something to
represent the activity. A research assistant will record the details of the activity (when,
what, if it was alone or in a group) and then the picture will be deleted.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06162897 -
Case Management Dyad
|
N/A | |
| Completed |
NCT03999411 -
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
|
Phase 4 | |
| Completed |
NCT02528773 -
Efficacy of ART to Interrupt HIV Transmission Networks
|
||
| Active, not recruiting |
NCT05454839 -
Preferences for Services in a Patient's First Six Months on Antiretroviral Therapy for HIV in South Africa
|
||
| Recruiting |
NCT05322629 -
Stepped Care to Optimize PrEP Effectiveness in Pregnant and Postpartum Women
|
N/A | |
| Completed |
NCT02579135 -
Reducing HIV Risk Among Adolescents: Evaluating Project HEART
|
N/A | |
| Active, not recruiting |
NCT01790373 -
Evaluating a Youth-Focused Economic Empowerment Approach to HIV Treatment Adherence
|
N/A | |
| Not yet recruiting |
NCT06044792 -
The Influence of Primary HIV-1 Drug Resistance Mutations on Immune Reconstruction in PLWH
|
||
| Completed |
NCT04039217 -
Antiretroviral Therapy (ART) Persistence in Different Body Compartments in HIV Negative MSM
|
Phase 4 | |
| Active, not recruiting |
NCT04519970 -
Clinical Opportunities and Management to Exploit Biktarvy as Asynchronous Connection Key (COMEBACK)
|
N/A | |
| Completed |
NCT04124536 -
Combination Partner HIV Testing Strategies for HIV-positive and HIV-negative Pregnant Women
|
N/A | |
| Recruiting |
NCT05599581 -
Tu'Washindi RCT: Adolescent Girls in Kenya Taking Control of Their Health
|
N/A | |
| Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
| Completed |
NCT02758093 -
Speed of Processing Training in Adults With HIV
|
N/A | |
| Completed |
NCT02500446 -
Dolutegravir Impact on Residual Replication
|
Phase 4 | |
| Completed |
NCT03805451 -
Life Steps for PrEP for Youth
|
N/A | |
| Active, not recruiting |
NCT03902431 -
Translating the ABCS Into HIV Care
|
N/A | |
| Completed |
NCT00729391 -
Women-Focused HIV Prevention in the Western Cape
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05736588 -
Elimisha HPV (Human Papillomavirus)
|
N/A | |
| Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 |